Advertisement

Growing Teratoma Syndrome with Port Site Metastasis

  • Garima Pandey
  • Pariseema S. DaveEmail author
Case Report
  • 4 Downloads

Introduction

Growing teratoma syndrome (GTS) is a rare condition among patients with non-seminomatous germ cell tumors who present with enlarging metastatic masses during appropriate systemic chemotherapy and in the context of normalized serum markers. Histology of lesions revealed benign mature teratomatous elements. The incidence of GTS after testicular NSGCT is 1.9–7.6%, while in the setting of ovarian germ cell neoplasia is unknown [1]. However, reports in the literature of GTS related to both testicular and ovarian carcinoma have grown in number. This may be because of increased awareness of this condition, improved imaging tools and the chemotherapeutic agents, which appear to potentially play a role in the etiology of this syndrome. We present a case of growing teratoma syndrome with port site metastasis where her initial management consisted of laparoscopy with the extraction of ovarian mass.

Case Report

A 22-year-old woman had laparoscopic removal of ovarian mass around...

Notes

Compliance with ethical standards

Conflict of interest

The authors declare that they have no conflict of interest.

References

  1. 1.
    Gorbatiy V, Spiess P, Pisters L. The growing teratoma syndrome: current review of the literature. Indian J Urol. 2009;25(2):186–9.CrossRefGoogle Scholar
  2. 2.
    Logothetis CJ, Samuels ML, Trindade A, et al. The growing teratoma syndrome. Cancer. 1982;50:1629–35.CrossRefGoogle Scholar
  3. 3.
    André F, Fizazi K, Culine S, et al. The growing teratoma syndrome: results of therapy and long-term follow-up of 33 patients. Eur J Cancer. 2000;36(11):1389–94.CrossRefGoogle Scholar
  4. 4.
    Denaro L, Pluchinotta F, Faggin R, et al. What’s growing on? the growing teratoma syndrome. Acta Neurochir. 2010;152(11):1943–6.CrossRefGoogle Scholar
  5. 5.
    Spiess PE, Kassouf W, Brown GA, et al. Surgical management of growing teratoma syndrome: the M. D. Anderson cancer center experience. J Urol. 2007;177(4):1330–4.CrossRefGoogle Scholar
  6. 6.
    De Cuypere M, Martinez A, Kridelka F, Balague G, Maisongrosse V, Ferron G. Disseminated ovarian growing teratoma syndrome: a case report highlighting surgical safety issues. Facts Views Vis Obgyn. 2014;6:250–3.PubMedPubMedCentralGoogle Scholar
  7. 7.
    Sengar AR, Kulkarni JN. Growing teratoma syndrome in a post laparoscopic excision of ovarian immature teratoma. J Gynecol Oncol. 2010;21:129–31.CrossRefGoogle Scholar
  8. 8.
    DiSaia PJ, Saltz A, Kagan AR, et al. Chemotherapeutic retroconversion of immature teratoma of the ovary. Obstet Gynecol. 1977;49:346.PubMedGoogle Scholar
  9. 9.
    Tonkin KS, Rustin GJS, Wignall B, Paradinas F, Bennett M. Successful treatment of patients in whom germ cell tumour masses enlarged on chemotherapy while their serum tumour markers decreased. Eur J Cancer Clin Oncol. 1989;25:1739–43.CrossRefGoogle Scholar
  10. 10.
    Mego M, Reckova M, Sycova-Mila Z, Obertova J, Brozmanova K, Salek T, Mardiak J. Bevacizumab in a growing teratoma syndrome. Case Rep. 2007;18:962–3.Google Scholar

Copyright information

© Association of Gynecologic Oncologists of India 2019

Authors and Affiliations

  1. 1.Gynaecologic Oncology DepartmentGujarat Cancer and Research Institute (GCRI)AhemedabadIndia

Personalised recommendations